To assess whether this higher expression of NSD1 can account for overall survival in patients with HCC, we first stratified patients into two groups: ones possessing high NSD1 expression (n = 32) or low NSD1 expression (n = 31) based on the median NSD1 expression value (n = 2.862). This evidence concerns the gene NSD1 and hepatocellular carcinoma.